Show simple item record

dc.contributor.advisorSamali, Afshin
dc.contributor.authorMcGrath, Eoghan Patrick
dc.date.accessioned2018-12-17T15:25:05Z
dc.date.issued2018-12-17
dc.identifier.urihttp://hdl.handle.net/10379/14726
dc.description.abstractMetastatic, drug resistant disease poses the greatest threat to the survival of breast cancer patients. Thus, elucidating and targeting mechanisms which govern this phenotype is a primary goal of the breast cancer field. Breast cancers manipulate cellular stress pathways to gain a survival advantage and fuel their growth. The unfolded protein response (UPR) is a major cell stress pathway responsible for the genesis and growth of many breast cancers. The most evolutionarily conserved transducer of the unfolded protein response is a protein called inositol-requiring enzyme 1 (IRE1), which is an important player in both luminal and basal-like breast cancers. Pro-tumour roles of IRE1 are mediated through its endoribonuclease (RNase) domain which has two functions, X-box binding protein 1 (XBP1) splicing and regulated IRE1-dependent decay (RIDD). In this thesis we have determined that the IRE1 RNase is particularly active in triple negative breast cancer (TNBC), a subtype with a poor prognosis and limited treatment options. We have discovered novel targets of the IRE1 RNase domain, namely C-X-C motif chemokine ligand 1 (CXCL1) which we have shown to govern a drug-resistant and stem cell-like phenotype. We also identified the first RIDD substrate in breast cancer (junction plakoglobin (JUP)) and found that its degradation by IRE1 may promote migration of TNBC cells. We employed MKC8866, a small molecule with clinical potential, to show that both of these processes can be blocked. This work highlights the promise of targeting IRE1 in the clinic to prolong and improve the lives of breast cancer patients.en_IE
dc.publisherNUI Galway
dc.subjectER stressen_IE
dc.subjectIRE1en_IE
dc.subjectbreast canceren_IE
dc.subjectunfolded protein responseen_IE
dc.subjecttherapy resistanceen_IE
dc.subjectJUPen_IE
dc.subjectCell Migrationen_IE
dc.subjectUnfolded Protein Response in Breast Canceren_IE
dc.subjectNatural Sciencesen_IE
dc.subjectBiochemistryen_IE
dc.subjectBreast canceren_IE
dc.subjectUnfolded protein responseen_IE
dc.titleInvestigating the role of IRE1α RNase activity in breast canceren_IE
dc.typeThesisen
dc.contributor.funderIrish Research Councilen_IE
dc.contributor.funderHorizon 2020en_IE
dc.local.noteBreast cancer cells activate stress response pathways to survive environments which normally kill other cells. IRE1 is a stress response protein which is constantly active in some cancer cells, and facilitates their survival. This thesis describes new roles for IRE1 in promoting breast cancer cell migration and therapy resistance.en_IE
dc.description.embargo2022-12-17
dc.local.finalYesen_IE
dcterms.projectinfo:eu-repo/grantAgreement/EC/H2020::MSCA-RISE/734749/EU/Targeting IRE1 in disease/INSPIREDen_IE
nui.item.downloads0


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record